Free tool
FAERS Monitor: Azacitidine
Last checked: Nov 20, 2026FDA FAERS (openFDA) last updated: Oct 28, 2026Methods & limitations
Reports naming NDA 208216 or its brand name (Azacitidine, Azacitidine). Reports on generic versions are filed under their own applications.
Reports
18,638
Serious
18,081
97% of reports
Hospitalization
8,444
Death reported
6,121
Any cause; not necessarily from the drug
Most reported reactions
MedDRA preferred terms.
- febrile neutropenia2,057
- death1,880
- myelosuppression1,698
- off label use1,620
- neutropenia1,457
- acute myeloid leukaemia1,318
- pneumonia1,084
- thrombocytopenia1,069
- pyrexia1,034
- drug ineffective1,026
- anaemia885
- infection705
- sepsis671
- pancytopenia657
- platelet count decreased642
Reports by year received
View as table
| Year | Reports |
|---|---|
| 2004 | 1 |
| 2005 | 3 |
| 2006 | 1 |
| 2007 | 5 |
| 2008 | 16 |
| 2009 | 43 |
| 2010 | 86 |
| 2011 | 119 |
| 2012 | 91 |
| 2013 | 78 |
| 2014 | 278 |
| 2015 | 404 |
| 2016 | 322 |
| 2017 | 670 |
| 2018 | 754 |
| 2019 | 942 |
| 2020 | 1,161 |
| 2021 | 1,981 |
| 2022 | 2,609 |
| 2023 | 2,465 |
| 2024 | 2,347 |
| 2025 | 2,559 |
| 2026 | 1,703 |
Disproportionality screen
Proportional reporting ratio (PRR): how much more often each reaction appears in this drug's reports than in the other 21,035,521 FAERS reports. Flagged when PRR is at least 2, chi-squared at least 4 and there are 3 or more reports (Evans criteria). A screening statistic only.
| Reaction | Reports | PRR | 95% CI lower | Chi-squared |
|---|---|---|---|---|
| acute myeloid leukaemiaSignal | 1,318 | 104.1 | 98.6 | 123,265 |
| myelosuppressionSignal | 1,698 | 55.8 | 53.2 | 87,146 |
| febrile neutropeniaSignal | 2,057 | 36.1 | 34.6 | 68,169 |
| pancytopeniaSignal | 657 | 13.4 | 12.4 | 7,466 |
| neutropeniaSignal | 1,457 | 12.2 | 11.6 | 14,924 |
| thrombocytopeniaSignal | 1,069 | 10.9 | 10.3 | 9,543 |
| platelet count decreasedSignal | 642 | 6.8 | 6.3 | 3,188 |
| sepsisSignal | 671 | 6.8 | 6.3 | 3,327 |
| infectionSignal | 705 | 5.5 | 5.1 | 2,609 |
| anaemiaSignal | 885 | 5.3 | 4.9 | 3,059 |
| pneumoniaSignal | 1,084 | 3.8 | 3.6 | 2,248 |
| pyrexiaSignal | 1,034 | 3.4 | 3.2 | 1,754 |
| deathSignal | 1,880 | 2.5 | 2.4 | 1,703 |
| off label useSignal | 1,620 | 2.1 | 2.0 | 958 |
| drug ineffective | 1,026 | 0.9 | 0.8 | 18 |
A high PRR for a reaction that is also the condition being treated (for example "disease progression" for a cancer drug) is expected and is not a safety signal.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.